Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation

Published:2016-04 Issue: Volume:57 Page:118-126
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Boudin Laurys,Chabannon Christian,Sfumato Patrick,Sabatier Renaud,Bertucci François,Tarpin Carole,Provansal Magali,Houvenaeghel Gilles,Lambaudie Eric,Tallet Agnes,Resbeut Michel,Charafe-Jauffret Emmanuelle,Calmels Boris,Lemarie Claude,Boher Jean-Marie,Extra Jean-Marc,Viens Patrice,Gonçalves Anthony

Funder

SIRIC

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients;Martino;Expert Opin Biol Ther,2012

2. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group;Stadtmauer;N Engl J Med,2000

3. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16;Crump;J Clin Oncol Off J Am Soc Clin Oncol,2008

4. High-dose chemotherapy for breast cancer: the French PEGASE experience;Roche;Cancer Control J Moffitt Cancer Cent,2003

5. Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial;Schmid;J Clin Oncol Off J Am Soc Clin Oncol,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022;Bone Marrow Transplantation;2022-05-19

2. Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review;Cancer Management and Research;2021-08

3. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019;Bone Marrow Transplantation;2019-04-05

4. Comparison of Different Dynamic Contrast Enhanced-Magnetic Resonance Imaging Descriptors and Clinical Findings Among Breast Cancer Subtypes Determined Based on Molecular Assessment;Iranian Journal of Radiology;2018-09-22

5. Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126];European Journal of Cancer;2016-11